Literature DB >> 11591124

Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.

M R Amel-Kashipaz1, M L Huggins, P Lanyon, A Robins, I Todd, R J Powell.   

Abstract

The production of type 1 (IFN-gamma, IL-2) and type 2 (IL-4, IL-5, IL-10, IL-13) cytokines by CD8(-) and CD8(+) T cells from systemic lupus erythematosus (SLE) patients and normal subjects was investigated using an intracellular cytokine-staining technique. This flow cytometric method facilitates analysis of both surface markers and cytoplasmic cytokines, after a short term (6 h) culture with or without phorbol myristate acetate and ionomycin (PMA/I) stimulation. In SLE patients, more unstimulated T cells produced IL-10 in comparison with controls; other cytokines were not detected in unstimulated cells. The percentage of IL-10-secreting T cells did not significantly increase after PMA/I stimulation of cells from SLE patients. The mean intensity of fluorescence (MIF) of intracellular IL-4 staining was significantly higher in CD8(-) T cells of SLE patients than controls. Significantly fewer CD8(-) and CD8(+) T cells from SLE patients secreted IFN-gamma after PMA/I stimulation compared with controls. The MIF and percentage of IL-2, IL-5, and IL-13-secreting cell subsets were not significantly different between SLE patients and controls. These findings indicate that T cells of SLE patients are already stimulated to produce IL-10 in vivo, which may result in downregulation of IFN-gamma secreting CD8(-) and CD8(+) T cells observed following PMA/I stimulation. Thus, the population size of Th1 and Tc1 cells are reduced in SLE patients whereas the effector function of Th2 cells, with respect to IL-4 production, is enhanced in SLE patients. Furthermore, although the balance between Th1/Th2 and between Tc1/Tc2 is disrupted in SLE patients, it is significantly biased in favour of the Th2 subset only. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591124     DOI: 10.1006/jaut.2001.0525

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  12 in total

1.  Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.

Authors:  Hiroshi Kato; Andras Perl
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

2.  Innate immune responses in lupus-prone Palmerston North mice: differential responses to LPS and bacterial DNA/CpG oligonucleotides.

Authors:  Petar Lenert; Adam Goeken; Barry S Handwerger; Robert F Ashman
Journal:  J Clin Immunol       Date:  2003-05       Impact factor: 8.317

3.  Synthesis and Biological Activities of 5-Thio-α-GalCers.

Authors:  Jingjing Bi; Jing Wang; Kai Zhou; Yuancheng Wang; Min Fang; Yuguo Du
Journal:  ACS Med Chem Lett       Date:  2015-02-11       Impact factor: 4.345

4.  Phenotypical changes and clinical significance of CD4+/CD8+ T cells in SLE.

Authors:  Shiwen Yuan; Yanting Zeng; Jiawei Li; Cuicui Wang; Weinian Li; Zhixiang He; Jinghua Ye; Fangfei Li; Yi Chen; Xiaojun Lin; Na Yu; Xiaoyan Cai
Journal:  Lupus Sci Med       Date:  2022-06

5.  Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus.

Authors:  Mary L Huggins; Ian Todd; Richard J Powell
Journal:  Rheumatol Int       Date:  2003-12-10       Impact factor: 2.631

6.  Cytokine-induced monocyte characteristics in SLE.

Authors:  Zhe Zhang; Kelly Maurer; Juan C Perin; Li Song; Kathleen E Sullivan
Journal:  J Biomed Biotechnol       Date:  2010-06-24

7.  Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells.

Authors:  M R Amel Kashipaz; D Swinden; I Todd; R J Powell
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

8.  Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients.

Authors:  Angela Luzia Branco Pinto Duarte; Andréa Tavares Dantas; Henrique de Ataíde Mariz; Flaviana Alves dos Santos; Juliana Cruz da Silva; Laurindo Ferreira da Rocha; Suely Lins Galdino; Maira Galdino da Rocha Pitta
Journal:  Mol Biol Rep       Date:  2013-05-06       Impact factor: 2.316

9.  Reducing progression of experimental lupus nephritis via inhibition of the B7/CD28 signaling pathway.

Authors:  Li Huang; Yong Kong; Jing Wang; Jie Sun; Qin Shi; Yu-Hua Qiu
Journal:  Mol Med Rep       Date:  2015-06-18       Impact factor: 2.952

10.  Elevated levels of CCR6+ T helper 22 cells correlate with skin and renal impairment in systemic lupus erythematosus.

Authors:  Wei Zhong; Yanfang Jiang; Hongshuang Ma; Jiang Wu; Zhenyu Jiang; Ling Zhao
Journal:  Sci Rep       Date:  2017-10-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.